• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ACO Transition & Assistance

Article

Panel members discuss what it will take for organizations to transition into an ACO and where they can obtain assistance.

In this segment, panel members discuss what it will take for organizations to transition into an ACO and where they can obtain assistance.

Related Videos
Jasmine Eugene, PharmD
JoAnn Pinkerton, MD
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Dr Brian Mulherin
Robert Andrews, former US representative for New Jersey and CEO of the Health Transformation Alliance
Related Content
The Top 5 IVBM Content of 2025

Top 5 Most-Read IVBM Content of 2025

December 24th 2025
Article

From oncology to cardiology, Institute for Value-Based Medicine® conversations highlighted the ways value-based care is reshaping access, equity, and outcomes.

Read More

managed care cast logo

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

June 10th 2025
Podcast

Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.

Listen

Our top ASCO 2025 highlights include new survival gains in key cancer trials, advances in AI-driven clinical decision support, and emerging evidence linking GLP-1 therapies to reduced cancer risk.

ICYMI: Highlights From ASCO 2025

December 22nd 2025
Article

ASCO 2025 highlighted breakthroughs, including improved cancer survival in key trials, new AI guideline tools, and expanding GLP-1 cancer research.

Read More

AJMC Managed Care Cast

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

December 31st 2024
Podcast

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

Listen

Vixarelimab shows rapid, sustained symptom relief and improved lesions in prurigo nodularis patients. | Image Credit: @this_baker-AdobeStock.jpeg

Phase 2b Trial Shows Vixarelimab Improves Itch and Lesions in Prurigo Nodularis

December 19th 2025
Article

A phase 2b trial found vixarelimab rapidly reduced itch and lesion burden in prurigo nodularis, with sustained benefit and a favorable safety profile.

Read More

Unmet health-related social needs, like housing and transportation, are associated with higher ED and inpatient use, highlighting opportunities for targeted interventions. | Image credit: @indysystem-AdobeStock.jpeg

Health-Related Social Needs Linked to Higher ED Use

December 16th 2025
Article

A new study finds patients with unmet social needs like housing or transportation face higher ED and inpatient use and that resolving these needs may reduce utilization.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.